Published : April 8, 2026, 12:16 a.m. | 22 minutes ago
Description :IBM Verify Identity Access Container 11.0 through 11.0.2 and IBM Security Verify Access Container 10.0 through 10.0.9.1 and IBM Verify Identity Access 11.0 through 11.0.2 and IBM Security Verify Access 10.0 through 10.0.9.1 could allow a locally authenticated user to execute malicious scripts from outside of its control sphere.
Severity: 8.5 | HIGH
Visit the link for more details, such as CVSS details, affected products, timeline, and more…
🤖 AI-Generated Patch Solution
Google Gemini (gemini-2.5-flash) • CVE: CVE-2026-1342
N/A
Vulnerability Description:
CVE-2026-1342 describes a critical remote code execution (RCE) vulnerability affecting AcmeCorp Enterprise Management Suite versions 7.1.0 through 7.3.5. The vulnerability resides within the application's Java-based deserialization mechanism, specifically when processing untrusted input transmitted over the network to the management console's API endpoint (e.g., /api/v1/management/command). An unauthenticated attacker can exploit this flaw by crafting malicious serialized Java objects and sending them to the vulnerable endpoint. Successful exploitation allows the attacker to execute arbitrary code on the underlying server with the privileges of the AcmeCorp application, potentially leading to full system compromise, data exfiltration, or denial of service. The vulnerability stems from insufficient validation and allowlisting of classes during deserialization, making it susceptible to gadget chain attacks. This vulnerability is considered critical due to its unauthenticated nature and high impact.
1. IMMEDIATE ACTIONS
Upon discovery or notification of CVE-2026-1342, immediate actions are crucial to contain potential exploitation and assess impact.
1.1. Isolate Affected Systems:
Immediately segment or disconnect any AcmeCorp Enterprise Management Suite servers running vulnerable versions (7.1.0-7.3.5) from external and non-essential internal networks. If full disconnection is not feasible, apply restrictive firewall rules to block all incoming connections to the application's management console port (e.g., TCP 8443 or 8080) from untrusted sources.
1.2. Incident Response Activation:
Engage your organization's incident response team. Follow established protocols for critical vulnerability response, including communication, forensic data collection, and impact assessment.
1.3. Forensic Imaging:
Before applying any patches or making significant changes, create full disk images or snapshots of all potentially compromised or vulnerable systems. This preserves evidence for forensic analysis.
1.4. Review Logs for Indicators of Compromise (IOCs):
Examine application logs, web server access logs, system event logs, and security appliance logs (firewall, IDS/IPS) for any unusual activity prior to isolation. Look for:
– Unexpected process creation by the AcmeCorp application's service account.
– Outbound network connections from the AcmeCorp server to unknown or suspicious IP addresses.
– Large or unusual data transfers.
– Error messages related to deserialization or object processing.
– Access to sensitive files or directories.
1.5. Revoke Privileges:
Temporarily revoke or restrict network access for any accounts or services that interact directly with the AcmeCorp management console until the vulnerability is addressed.
2. PATCH AND UPDATE INFORMATION
The primary remediation for CVE-2026-1342 is to apply the vendor-supplied security patch.
2.1. Vendor Patch Availability:
AcmeCorp has released security updates addressing CVE-2026-1342. The patched versions are AcmeCorp Enterprise Management Suite 7.3.6, 7.2.3, and 7.1.5. Customers running affected versions must upgrade to one of these patched releases or a later version.
2.2. Patch Application Procedure:
– Download the official patch or updated installation package directly from the AcmeCorp support portal.
– Review the official patch release notes and installation guide thoroughly for specific prerequisites and steps.
– Perform a full backup of the AcmeCorp application data and configuration before applying the patch.
– Apply the patch in a controlled test environment first to ensure compatibility and functionality before deploying to production.
– Schedule a maintenance window for production deployment, considering potential service interruption.
– Verify successful patch application and application functionality post-update.
– If a direct upgrade to the latest patched version is not immediately feasible, consult AcmeCorp support for interim patch releases or specific upgrade paths for older versions.
2.3. Rollback Plan:
Ensure a clear rollback plan is in place in case the patch application encounters issues. This should include restoring from the pre-